Dr. Navdeep Tangri

Award: KRESCENT New Investigator Award
Institution: University of Manitoba
Year: 2013-2016

Lay Summary

Dr. Navdeep Tangri is a new investigator at the University of Manitoba where he obtained his M.D. He completed a KRESCENT Post-Doctoral Fellowship in Nephrology Clinical Research with Dr. Andrew Levey at the Tufts University in Boston where he also completed his Ph.D. in Clinical and Translational Science. Dr. Tangri’s research focuses on the outcomes of chronic kidney diseases (CKD).

CKD affects over one million Canadians and causes an increased risk of heart disease and dialysis. The aim of Dr. Tangri’s research is to study patients with atrial fibrillation (AF), an abnormal heart rhythm, and CKD. Atrial fibrillation can lead to strokes by forming blood clots in the heart and it is usually treated with the use of blood thinners. However, these anticoagulants have side effects including major bleeding. More precisely, Dr. Tangri will look at the long term risk of strokes and bleeding in patients with CKD to determine whether blood thinners are safe and effective in this population. Findings will help doctors provide better treatments for CKD patients and reduce the risk of strokes and bleeding in this population.